Human placental trophoblasts secrete a disintegrin metalloproteinase very similar to the insulin-like growth factor binding protein-3 protease in human pregnancy serum

Endocrinology

Volumn 141, Issue 2, 2000, Pages 666-674

  Irwin, J C ^a   Suen, L F ^a   Cheng, B H ^a   Martin, R ^a   Cannon, P ^a   Deal, C L ^a   Giudice, L C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; ALPHA 2 ANTIPLASMIN; APROTININ; ASPARTIC PROTEINASE INHIBITOR; CYSTEINE PROTEINASE INHIBITOR; DISINTEGRIN; EDETIC ACID; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PROTEINASE; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; BINDING AFFINITY; CELL AGGREGATION; CELL DIFFERENTIATION; CELL FUSION; CYTOTROPHOBLAST; ENDOMETRIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN TISSUE; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; TROPHOBLAST;

EID: 0034463157     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.2.7292     Document Type: Article

References (54)

1. Insulin-like growth factors and their binding proteins
2. Insulin-like growth factor binding proteins (IGFBPs): Physiological and metabolic roles
3. Regulation and physiological role of insulin-like growth factor binding proteins
4. Role of insulin-like growth factor binding proteins in controlling IGF actions
5. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
6. 1 integrin by means of its Arg-Gly-Asp sequence
7. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 on Hs578T human breast cancer cells
8. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
9. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action
10. Insulin-like growth factor binding protein proteolysis in bone cell models
11. Matrix metalloproteinases as insulin-like growth factor binding protein proteases protein-degrading proteinases
12. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
13. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I
14. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins
15. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
16. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the "150K" complex during pregnancy
17. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity
18. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: Effects of hypophysectomy and an IGFBP-specific serum protease activity
19. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy
20. Proteolysis of insulin-like growth factor binding proteins by a novel 50 kilodalton metalloproteinase in human pregnancy serum
21. Adhesive and degradative properties of human placental cytotrophoblast
22. 1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures
23. Hormonal regulation of human endometrial stromal cells In culture: An in vitro model for decidualization
24. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells
25. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae
26. The human villous cytotrophoblast: Interactions with extracellular matrix proteins, endocrine function, and cytoplasmic differentiation in the absence of syncytium formation
27. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts
28. Human cytotrophoblast invasion
29. A simple assay for proteolysis of IGFBP-3
30. Matrix metalloproteinase inhibition limits arterial enlargement in a rodent arteriovenous fistula model
31. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cultures: Evidence for a novel mechanism of ligand-induced proteolysis
32. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
33. Identification of insulin-like growth factor-binding protein-2 (IGF-BP-2) in human seminal plasma
34. Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood and sera of healthy adults, pregnant women and patients with trophoblastic disease
35. Measurement and characterization of insulin-like growth factor binding protein-3 in human fluids: Discrepancies between radioimmunoassay and ligand blotting
36. Insulin-like growth factor (IGF) and IGF binding proteins in extra-embryonic cavities in early human pregnancy: Potential relevance to maternal-embryonic communication
37. Metalloproteinases and their inhibitors in matrix remodeling
38. Matrix metalloproteinases: A review
39. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases
40. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
41. Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells
42. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation
43. Cloning of a disintegrin metalloproteinase that processes precursor
44. Profiles of Insulin-like growth factor binding proteins and the protease activity in the maternal circulation and its local regulation between placenta and decidua
45. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy
46. Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3
47. Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: Quantitative measurements by radioimmunoassay in human fetal serum
48. Insulin-like growth factors and their binding proteins in term and pre-term human fetus and neonate with normal and extremes of intrauterine growth
49. Insulin-like growth factor binding proteins in sera of pregnant nonhuman primates
50. Insulin-like growth factor-II (IGF-II) inhibits TIMP- 3 production by decidualized human endometrial stromal cells: Possible role in trophoblast invasiveness in human implantation
51. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3
52. A metalloproteinase disintegrin that releases tumournecrosis factor-α from cells
53. Synthesis of placental protein 12 by human decidua
54. Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation